Howe & Rusling’s Atreca, Inc. Class A Common Stock BCEL Stock Holding History

Howe & Rusling’s Portfolio BCEL Stock Details BCEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50	Closed	–	–	1224
2022 Q2	$0	Buy	+50	New	+$104	﹤0.01%	1186

Other funds holding BCEL

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return

LCM

Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

Howe & Rusling's BCEL Position: Q3 2022 in Review

Howe & Rusling sold out of Atreca, Inc. Class A Common Stock (BCEL) in Q3 2022, closing a stake of 50 shares.

Howe & Rusling first reported a position in BCEL in Q2 2022 and held it in 1 quarter. The position peaked at $0 in Q2 2022. 65 funds tracked by Wall St. Rank hold BCEL as of Q3 2022.

Howe & Rusling reported no remaining Atreca, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Howe & Rusling sold 50 Atreca, Inc. Class A Common Stock shares in Q3 2022.
Howe & Rusling first reported a position in Atreca, Inc. Class A Common Stock in Q2 2022 and held it in 1 quarter.
Howe & Rusling's Atreca, Inc. Class A Common Stock position peaked at $0 in Q2 2022.
65 funds tracked by Wall St. Rank held Atreca, Inc. Class A Common Stock as of Q3 2022.

Based on Howe & Rusling's 13F filing for Q3 2022, filed 14 Nov 2022.